Neuberger Berman Group
FLXN

Neuberger Berman Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Neuberger Berman Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-645,600
Closed -$7.45M – 1848
2020
Q4 		$7.45M Sell
645,600
-50,000
-7% -$581K 0.01% 833
2020
Q3 		$7.24M Buy
695,600
+300
+0% +$3.68K 0.01% 783
2020
Q2 		$9.14M Buy
695,300
+300
+0% +$3.11K 0.01% 736
2020
Q1 		$5.47M Buy
+695,000
New +$10.5M 0.01% 778

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Neuberger Berman Group's FLXN Position: Q1 2021 in Review

Neuberger Berman Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2021, closing a stake of 645,600 shares — an estimated $7.45M sold.

Neuberger Berman Group first reported a position in FLXN in Q1 2020 and held it in 4 quarters. The position peaked at $9.14M in Q2 2020. 145 funds tracked by Wall St. Rank hold FLXN as of Q1 2021.

  • Neuberger Berman Group reported no remaining Flexion Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Neuberger Berman Group sold 645,600 Flexion Therapeutics, Inc. shares in Q1 2021, an estimated $7.45M.
  • Neuberger Berman Group first reported a position in Flexion Therapeutics, Inc. in Q1 2020 and held it in 4 quarters.
  • Neuberger Berman Group's Flexion Therapeutics, Inc. position peaked at $9.14M in Q2 2020.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2021.

Based on Neuberger Berman Group's 13F filing for Q1 2021, filed 13 May 2021.